By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Inotek Pharmaceuticals Corporation 

100 Cummings Center
Suite 419E
Beverly  Massachusetts  01915  U.S.A.
Phone: 978-232-9660 Fax: 978-232-8975



Company News
Inotek (ITEK) Plunges On Failed Phase III Glaucoma Trial 1/3/2017 5:31:17 AM
Inotek (ITEK) Reports Third Quarter 2016 Financial Results And Operational Highlights 11/9/2016 10:44:41 AM
Inotek (ITEK) To Present At The 2016 Ophthalmology Innovation Summit 10/7/2016 10:33:59 AM
Inotek (ITEK) Appoints Timothy Barberich To Board Of Directors 9/29/2016 12:38:46 PM
Inotek (ITEK) Announces Participation At Upcoming Investor Conferences 9/6/2016 11:31:10 AM
Inotek (ITEK) Announces The Completion Of The Recruitment Phase Of MATrX-1, The First Phase 3 Clinical Trial Of Trabodenoson For Glaucoma 8/24/2016 9:39:19 AM
Inotek (ITEK) Appoints Patrick Machado, JD, To Board Of Directors 8/18/2016 10:49:02 AM
Inotek (ITEK) Reports Second Quarter 2016 Financial Results And Operational Highlights 8/10/2016 11:21:21 AM
Inotek (ITEK) Announces Pricing Of $50.0 Million Of 5.75% Convertible Senior Notes Due 2021 8/2/2016 11:48:06 AM
Inotek Pharmaceuticals Corporation (ITEK) Expands Intellectual Property Portfolio With Combination Patent 7/22/2016 9:04:48 AM